The Patient Voice Initiative began in 2015 when a group of stakeholders from industry, academia and patient groups came together to discuss methodologies and approaches for eliciting the patient perspective on the value of medicines. As a result of these meetings a conference was organised aimed at increasing patient engagement in health technology assessment (HTA) in Australia. Following the conference, a steering committee was formed to action items generated from the workshops. The current steering committee membership is: Jessica Bean (Chair), patient advocate Todd Stephenson (Secretary), Janssen Australia and New Zealand Ann Single, consumer advocate Kate Vines, Rare Cancers Australia Simon Fifer, CaPPRe Hayley Anderson, BMS Australia